Benign prostatic hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria were age >50 yr, ECOG performance status less than 3, acute urinary retention if catheter removal failed after therapy with a-blockers or chronic urinary retention unresponsive to medical treatment, International Prostate Symptom Score (IPSS) more than 15.
Exclusion criteria
Exclusion criteria: Exclusion criteria were patients with documented or suspected prostate cancer, bladder calculus, neurogenic bladder, previous prostate surgery, renal impairment, associated hydronephrosis, and urethral stricture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end point in this study was safety, with a focus on perioperative findings such as operation time, decline of sodium level, clot retention, transfusion, and any other symptom relating to the procedures. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints were efficacy findings for patients after 36 months of follow-ups including development of urethral stricture. | — |
Countries
Japan